Scarica l'app Stockscreener
42.13
0.87%
-0.37
Dopo l'orario di chiusura:
42.13
Precedente Chiudi:
$42.50
Aprire:
$42
Volume 24 ore:
1.25M
Relative Volume:
0.45
Capitalizzazione di mercato:
$8.70B
Reddito:
$2.10B
Utile/perdita netta:
$402.17M
Rapporto P/E:
21.76
EPS:
1.9357
Flusso di cassa netto:
$403.87M
1 W Prestazione:
-3.94%
1M Prestazione:
-3.92%
6M Prestazione:
-2.02%
1 anno Prestazione:
-8.43%
Intervallo 1D:
$41.89
$42.62
Intervallo di 1 settimana:
$41.89
$43.66
Portata 52W:
$32.53
$57.81
Qiagen Nv Stock (QGEN) Company Profile
Nome
Qiagen Nv
Settore
Industria
Telefono
-
Indirizzo
-
Compare QGEN vs TMO, DHR, NTRA, IQV, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
42.13 | 8.78B | 2.10B | 402.17M | 403.87M | 1.9357 |
TMO
Thermo Fisher Scientific Inc
|
603.18 | 223.95B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
200.53 | 144.01B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
326.14 | 47.61B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
257.30 | 42.30B | 16.63B | 1.39B | 2.12B | 8.0674 |
A
Agilent Technologies Inc
|
143.12 | 40.81B | 7.23B | 1.41B | 1.09B | 4.979 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-14 | Downgrade | Barclays | Overweight → Equal Weight |
| 2026-03-13 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2026-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2025-06-24 | Iniziato | Barclays | Overweight |
| 2025-04-04 | Downgrade | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-10-17 | Downgrade | HSBC Securities | Buy → Hold |
| 2024-06-27 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | Iniziato | Wells Fargo | Equal Weight |
| 2023-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2023-12-07 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-09-12 | Iniziato | Robert W. Baird | Outperform |
| 2023-05-23 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-01-18 | Aggiornamento | DZ Bank | Hold → Buy |
| 2021-10-15 | Ripresa | Cowen | Market Perform |
| 2021-10-14 | Iniziato | Redburn | Buy |
| 2021-07-14 | Downgrade | Kepler | Buy → Hold |
| 2021-06-03 | Iniziato | Goldman | Neutral |
| 2020-10-06 | Ripresa | BofA Securities | Buy |
| 2020-09-28 | Aggiornamento | Kepler | Hold → Buy |
| 2020-08-24 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-08-17 | Aggiornamento | Berenberg | Hold → Buy |
| 2020-08-14 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-08-14 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | Downgrade | Berenberg | Buy → Hold |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-12-26 | Ripresa | BofA/Merrill | Underperform |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-11-14 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-11-14 | Aggiornamento | JP Morgan | Underweight → Overweight |
| 2019-11-14 | Aggiornamento | Kepler | Reduce → Hold |
| 2019-10-17 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | Downgrade | Kepler | Hold → Reduce |
| 2019-10-08 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-10-08 | Downgrade | Deutsche Bank | Buy → Hold |
| 2019-10-08 | Downgrade | JP Morgan | Neutral → Underweight |
Mostra tutto
Qiagen Nv Borsa (QGEN) Ultime notizie
Qiagen (NYSE:QGEN): Is This Valuation Mispriced? - Kalkine Media
Qiagen stock edges higher as Bank of America lifts stake and UBS trims target - ad-hoc-news.de
symbol__ Stock Quote Price and Forecast - CNN
Qiagen stock heads into the open after a 0.28% gain - ad-hoc-news.de
Bank of America lifts Qiagen voting rights stake to 5.03% - Bitget
Qiagen grants performance-linked share units to CEO under MAR disclosure - The Globe and Mail
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Release according to Article 40, Section 1 of the WpHG - TradingView
QGEN Maintained by UBS -- Price Target Lowered to $47.00 - GuruFocus
Qiagen N.V. Announces Resignation of Thierry Bernard as Member of Managing Board, Effective from September 1, 2026 - marketscreener.com
Qiagen (NYSE:QGEN): Can Its New Launch Unlock Value? - Kalkine Media
UBS Adjusts Price Target on QIAGEN to $47 From $52, Keeps Neutral Rating - marketscreener.com
Qiagen stock holds steady as analysts see limited upside - ad-hoc-news.de
New CEO to lead Qiagen (NYSE: QGEN) as board reviews strategy - Stock Titan
Qiagen N.V. $QGEN Stake Reduced by Allianz Asset Management GmbH - MarketBeat
Qiagen stock heads into the open after a 0.25 percent dip - ad-hoc-news.de
PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView
Managers' transactions announcement according to article 19 MAR - tradingview.com
Groupe la Francaise Has $3.25 Million Stake in Qiagen N.V. $QGEN - MarketBeat
Qiagen stock heads into the open after a 2.0 percent drop - ad-hoc-news.de
Qiagen stock edges lower as investors look beyond recent earnings - ad-hoc-news.de
Qiagen N.V. (QGEN) Stock Analysis: Exploring The 5.98% Potential Upside For Investors - DirectorsTalk Interviews
New CEO took over the reins - European Biotechnology Magazine
Qiagen stock heads into the open after a muted move on Xetra - ad-hoc-news.de
Public Employees Retirement System of Ohio Purchases New Shares in Qiagen N.V. $QGEN - MarketBeat
Qiagen (QGEN) Beat Q2 Estimates And Reaffirmed Outlook, Is It Still Below Fair Value? - Yahoo Finance
Qiagen N.V.ADR Key Financial Ratios – Valuation, Profitability & More - Value Research
Qiagen stock trades around 43 dollars as investors watch margins and diagnostics demand - ad-hoc-news.de
Qiagen (QGEN) Up 5.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Global Multiplex Assays Market 2026 Edition - GlobeNewswire Inc.
Qiagen stock holds steady as margins and stake disclosure support valuation - AD HOC NEWS
BlackRock Discloses Significant Stake in Qiagen Under AFM Rules - The Globe and Mail
Qiagen stock holds near 43 dollars as stake disclosure and margins support valuation - AD HOC NEWS
Qiagen stock holds near 43 dollars after steady analyst view - AD HOC NEWS
Qiagen NV at Citi Global Healthcare Conference Transcript - GuruFocus
Qiagen stock steadies near 43 dollars as latest quarter shows modest growth - AD HOC NEWS
Qiagen NV Annual Shareholders Meeting Transcript - GuruFocus
Q3 2025 Qiagen NV Earnings Call Transcript - GuruFocus
Qiagen stock holds mid-40 dollar level as analysts stick to hold ratings - AD HOC NEWS
Plant Virome Diagnostics Outlook 2026-2030 Featuring Profiles of Illumina, Thermo Fisher Scientific and Qiagen - Yahoo Finance
Qiagen N.V. (NYSE:QGEN) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
List of 26 Acquisitions by Qiagen (Sep 2026) - Tracxn
Qiagen stock steadies around $43 as investors digest legal and ownership signals - AD HOC NEWS
Jury Awards 10x Genomics Millions in Patent Lawsuit Against Qiagen Unit - Benzinga
Qiagen N.V. (QGEN) Stock Analysis: Navigating Potential Upside In Healthcare Diagnostics - DirectorsTalk Interviews
Delaware jury finds Parse infringed three genetic-sequencing patents - Reuters
Wellington Management Group LLP Trims Stock Position in Qiagen N.V. $QGEN - MarketBeat
Goldman Sachs Revealed as 2.97% Shareholder in Qiagen via AFM Filing - The Globe and Mail
Bank of America Reports 4.69% Stake in Qiagen - The Globe and Mail
Could Qiagen (QGEN) Stock Win as Its FDA Clearance Opens a New Diagnostics Market? - Yahoo Finance
10x Genomics wins jury award in Qiagen patent row (TXG:NASDAQ) - Seeking Alpha
Qiagen Nv Azioni (QGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):